Literature DB >> 3555767

Transport of molecules in the tumor interstitium: a review.

R K Jain.   

Abstract

The transport of fluid and solute molecules in the interstitium is governed by the biological and physicochemical properties of the interstitial compartment as well as the physicochemical properties of the test molecule. The composition of the interstitial compartment of neoplastic tissues is significantly different from that of most normal tissues. In general the tumor interstitial compartment is characterized by large interstitial space, high collagen concentration, low proteoglycan and hyaluronate concentrations, high interstitial fluid pressure and flow, absence of anatomically well-defined functioning lymphatic network, high effective interstitial diffusion coefficient of macromolecules, as well as large hydraulic conductivity and interstitial convection compared to most normal tissues. While these factors favor movement of macromolecules in the tumor interstitium, high interstitial pressure and low microvascular pressure may retard extravasation of molecules and cells, especially in large tumors. These differences in transport parameters have major implications in tumor growth and metastases, as well as in tumor detection and treatment.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3555767

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  362 in total

Review 1.  Intravital fluorescence videomicroscopy to study tumor angiogenesis and microcirculation.

Authors:  P Vajkoczy; A Ullrich; M D Menger
Journal:  Neoplasia       Date:  2000 Jan-Apr       Impact factor: 5.715

2.  A mathematical model for comparison of bolus injection, continuous infusion, and liposomal delivery of doxorubicin to tumor cells.

Authors:  A W El-Kareh; T W Secomb
Journal:  Neoplasia       Date:  2000 Jul-Aug       Impact factor: 5.715

3.  Ultrasound-enhanced drug transport and distribution in the brain.

Authors:  Ying Liu; Sumit Paliwal; Krystof S Bankiewicz; John R Bringas; Gill Heart; Samir Mitragotri; Mark R Prausnitz
Journal:  AAPS PharmSciTech       Date:  2010-06-08       Impact factor: 3.246

4.  Equilibrium and kinetic studies of the interactions of a porphyrin with low-density lipoproteins.

Authors:  Stéphanie Bonneau; Christine Vever-Bizet; Patrice Morlière; Jean-Claude Mazière; Daniel Brault
Journal:  Biophys J       Date:  2002-12       Impact factor: 4.033

5.  Liposome formulation of NSC-639829 using halothane as a solvent: a technical note.

Authors:  Akash Jain; Tapan Sanghvi; Samuel H Yalkowsky
Journal:  AAPS PharmSciTech       Date:  2003-10-15       Impact factor: 3.246

Review 6.  Nonviral DNA vectors for immunization and therapy: design and methods for their obtention.

Authors:  Ernesto G Rodríguez
Journal:  J Mol Med (Berl)       Date:  2004-06-03       Impact factor: 4.599

7.  Ionic versus nonionic paramagnetic contrast media in differentiating between postoperative scar and recurrent disk.

Authors:  Jui-Sheng Hsu; Gin-Chung Liu; Shih-Hsien Chen; Twei-Shiun Jaw; Wun-Jer Shen; Chiao-Yun Chen
Journal:  AJNR Am J Neuroradiol       Date:  2004 Jun-Jul       Impact factor: 3.825

8.  A theoretical model for intraperitoneal delivery of cisplatin and the effect of hyperthermia on drug penetration distance.

Authors:  Ardith W El-Kareh; Timothy W Secomb
Journal:  Neoplasia       Date:  2004 Mar-Apr       Impact factor: 5.715

9.  Front instabilities and invasiveness of simulated avascular tumors.

Authors:  Nikodem J Popławski; Ubirajara Agero; J Scott Gens; Maciej Swat; James A Glazier; Alexander R A Anderson
Journal:  Bull Math Biol       Date:  2009-02-21       Impact factor: 1.758

10.  Collagen-binding proteoglycan fibromodulin can determine stroma matrix structure and fluid balance in experimental carcinoma.

Authors:  Ake Oldberg; Sebastian Kalamajski; Alexei V Salnikov; Linda Stuhr; Matthias Mörgelin; Rolf K Reed; Nils-Erik Heldin; Kristofer Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-22       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.